Crossref
In Brief: Alternatives to Mifepristone for Medication Abortion
The Medical Letter on Drugs and Therapeutics · 2023
DOI: 10.58347/tml.2023.1679d ↗Kurz gefasst
Fachartikel in der Zeitschrift The Medical Letter on Drugs and Therapeutics, 2023. Hauptthemen laut MEDLINE: Abortion, Induced, Abortifacient Agents, Steroidal, Misoprostol, Abortifacient Agents, Nonsteroidal.
Abstract (Originalsprache)
The possibility that use of mifepristone (Mifeprex, and generics) may be restricted has led to questions about alternatives for medication abortion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Abortion, InducedAbortifacient Agents, SteroidalMisoprostolAbortifacient Agents, NonsteroidalPregnancyFemaleHumansMifepristone
Stichwörter der Autor:innen
CytotecMifeprexadverse effectsdosageefficacyletrozolemethotrexatemifepristonemisoprostolsafety
Substanzen
MifepristoneAbortifacient Agents, SteroidalMisoprostolAbortifacient Agents, Nonsteroidal
Zitieren
APA
(2023). In Brief: Alternatives to Mifepristone for Medication Abortion. The Medical Letter on Drugs and Therapeutics. https://doi.org/10.58347/tml.2023.1679d
Vancouver
In Brief: Alternatives to Mifepristone for Medication Abortion. The Medical Letter on Drugs and Therapeutics. 2023. doi:10.58347/tml.2023.1679d
BibTeX
@article{euvimed2023,
title = {In Brief: Alternatives to Mifepristone for Medication Abortion},
journal = {The Medical Letter on Drugs and Therapeutics},
year = {2023},
doi = {10.58347/tml.2023.1679d}
}
EUVIMED